What does "Shortage" refer to in the pharmaceutical industry?

In the pharmaceutical industry, a Shortage refers to a state of supply deficit, stockouts, or severe scarcity of medications. Caused by factors such as manufacturing disruptions, raw material (API) shortages, or geopolitical risks, the inability to deliver essential drugs to clinical settings has become a critical global challenge.

Supply Chain Resilience & Risk Mitigation

Information Transparency:
For international healthcare professionals, understanding the domestic supply status in Japan is vital for procurement planning. 'synapse' publishes a 'Medical Supply Information List' reflecting the latest market trends to eliminate information asymmetry.

Proactive Risk Management:
By visualizing detailed statuses such as 'Limited Shipment' or 'Supply Suspension,' we help users avoid stockout issues after ordering, ensuring high-certainty procurement.

Hub for Alternative Sourcing:
When a specific product faces a shortage, we provide rapid information on the availability of therapeutic equivalents or generic alternatives. Leveraging our extensive Japanese network, we support 'Continuity of Care' for medical facilities worldwide.

Strategic Advantage of synapse.net

In an era of supply instability, data-driven decision-making is indispensable. 'synapse' integrates Kosei Pharmaceutical's robust domestic inventory with real-time market data, serving as the most reliable supply partner in an uncertain global market.